GXV813, GXV813, Placebo 0 mg Hard gelatin capsule clinical trials

A Phase 2a, Randomized, Participant- and Investigator blinded, Parallel-group, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults with DSM-5 Schizophrenia (STAR-1)

This study is testing a new medicine, GXV813, for adults in hospital with schizophrenia. Researchers want to see if it's safe, how well people tolerate it, and if it helps with symptoms after six weeks compared to a dummy pill. It's an early-stage study to understand the medicine better.